Live attenuated vaccines are produced from the pathogens which are weakened at such a level that they can grow in vaccinated person but causes no or mild disease formation. These vaccines helps in creating the immune response which protects the vaccinated individual from acquiring the same disease. The WHO recommended vaccines such as BCG, polio vaccine, measles, rotavirus and yellow fever are made by attenuation.
MARKET DYNAMICS
The live attenuated vaccines market is expected to grow during the forecast period due to awareness regarding vaccination, hike in funding by government to and steps taken to make vaccination compulsory for children. Furthermore, the growing occurrence of infectious diseases are providing the opportunity to market.
MARKET SCOPE
The "Global Live Attenuated Vaccines Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of live attenuated vaccines market with detailed market segmentation by type, end user and geography. The global live attenuated vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading live attenuated vaccines market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global live attenuated vaccines market is segmented on the basis of type and end user. Based on type, the market is classified as viral and bacterial. On the basis of end user, the market is classified as hospitals, clinics, research institutes and other end users.
(image)
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global live attenuated vaccines market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The live attenuated vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting live attenuated vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the live attenuated vaccines market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the live attenuated vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from live attenuated vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for live attenuated vaccines market in the global market. Below mentioned is the list of few companies engaged in the live attenuated vaccines market.
The report also includes the profiles of key live attenuated vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-Emergent BioSolutions Inc.
-GlaxoSmithKline plc
-BioDiem
-AstraZeneca
-Merck & Co., Inc.
-Pfizer Inc.
-Sanofi
-Serum institute of India Pvt. Ltd.
-CSL Limited
-Vivaldi Biosciences Inc.
(image)